Bajaj Healthcare Ltd Share Price
(BAJAJHCARE)
₹631.05▲1.02%
as on 11:22AM, 24 Apr 2025
Bajaj Healthcare Performance
Day's Low
Day's High
₹622Day's Price Range₹642.852 Week's Low
52 Week's High
₹263.352-Week Price Range₹745
| Returns % | |
| 1 Month Return | -9.54 % |
| 3 Month Return | + 11.81 % |
| 1 Year Return | + 86.99 % |
| Market Stats | |
| Previous Close | ₹624.65 |
| Open | ₹631.05 |
| Volume | 1.10L |
| Upper Circuit | ₹749.55 |
| Lower Circuit | ₹499.75 |
| Market Cap | ₹1,972.85Cr |
Bajaj Healthcare Fundamentals
P/E Ratio
0PEG Ratio
0Market Cap
₹1,972.85 Cr
P/B Ratio
2.9
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
-12.23
Mutual Fund Holdings of Bajaj Healthcare
| Funds | Holdings | Prev. 5M |
|---|---|---|
 HDFC Pharma and Healthcare Fund Direct Growth | 0.43% |
Key events for Bajaj Healthcare Ltd
Bajaj Healthcare Appoints New CFO - 11 Apr, 2025
Bajaj Healthcare Ltd has appointed Rohan Parekh as Chief Financial Officer, with the appointment effective from April 16, 2025, as approved by the Board.Bajaj Healthcare Acquires GenRx Pharmaceuticals for Growth - 08 Apr, 2025
Bajaj Healthcare announced the acquisition of GenRx Pharmaceuticals for ₹10.85 crore to strengthen its manufacturing capabilities. The deal is expected to complete within 3-6 months, subject to regulatory approvals. The acquisition aligns with the company's strategic initiative for growth and value creation.Bajaj Healthcare Shows Growth Amid Financial Concerns - 24 Mar, 2025
Bajaj Healthcare's stock has surged over 130% in a year, driven by new drug approvals and global expansion. However, its financial history raises concerns, with declining revenues and increasing debt. The company is taking steps to improve profitability and has posted profits in FY25 so far, but its high price-to-book value ratio suggests caution for investors.Bajaj Healthcare Secures Approval for Drug Trials - 19 Mar, 2025
Bajaj Healthcare's shares surged nearly 10% after receiving approval from SEC-CDSCO for Phase III clinical trials of Cenobamate, an anti-seizure medication. The stock reached a record high, reflecting strong market interest and potential for future growth.
Insights on Bajaj Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 1.31% to 1.64% in Dec 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, BAJAJHCARE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 55.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.19% of holdings in Dec 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 37.78% to 37.45% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, BAJAJHCARE stock has moved down by -11.2%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 1.07% to 1.01% in Dec 2024 quarter
Bajaj Healthcare Financials
Bajaj Healthcare Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 59.19% | 0.00 | |
| Foreign Institutions | 1.01% | ||
| Mutual Funds | 1.64% | 25.19 | |
| Retail Investors | 37.45% | ||
| Others | 0.72% | 9.67 |
Bajaj Healthcare Key Indicators
Bajaj Healthcare Earnings and Dividends
Bajaj Healthcare Ltd Earnings Results
Bajaj Healthcare Ltd’s net profit jumped 632.73% since last year same period to ₹11.72Cr in the Q3 2024-2025. On a quarterly growth basis, Bajaj Healthcare Ltd has generated 23.89% jump in its net profits since last 3-months.
Read More about Earnings ResultsBajaj Healthcare Ltd Dividends May,2024
In the quarter ending March 2024, Bajaj Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.32%.
Read More about Dividends
Bajaj Healthcare Technicals Summary
Bearish
Neutral
Bullish
Bajaj Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Bajaj Healthcare Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,972.85 Cr | 14.42% | 0.79 | NA | NA | |
| NA | ₹11.15 Cr | 66.72% | 0.50 | NA | NA | |
| NA | ₹2,987.44 Cr | 39.26% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| NA | ₹520.52 Cr | 260.56% | 0.73 | ₹7 Cr | ₹1 Cr | |
| NA | ₹157.93 Cr | 105.19% | 0.69 | NA | NA |
About Bajaj Healthcare
Listing date: 25 Nov, 2021
Chairperson Name: Sanjankumar R Bajaj
| Organisation | Bajaj Healthcare |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Bajaj Healthcare Ltd
What is Bajaj Healthcare Ltd price today?
Bajaj Healthcare Ltd share price today stands at ₹631.05, Open: ₹631.05, Previous Close: ₹624.65, High: ₹642.8, Low: ₹622, 52 Week High: ₹745, 52 Week Low: ₹263.3.
How to Buy Bajaj Healthcare Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Bajaj Healthcare Ltd shares
What are today's traded volumes of Bajaj Healthcare Ltd?
Today's traded volume of Bajaj Healthcare Ltd(BAJAJHCARE) is 1.10L.
What is today's market capitalisation of Bajaj Healthcare Ltd?
Today's market capitalisation of Bajaj Healthcare Ltd(BAJAJHCARE) is ₹1972.85Cr.
What is the 52 Week High and Low Range of Bajaj Healthcare Ltd?
How much percentage Bajaj Healthcare Ltd is down from its 52 Week High?
Bajaj Healthcare Ltd (BAJAJHCARE) share price is ₹631.05. It is down -15.30% from its 52 Week High price of ₹745
How much percentage Bajaj Healthcare Ltd is up from its 52 Week low?
Bajaj Healthcare Ltd (BAJAJHCARE) share price is ₹631.05. It is up 139.67% from its 52 Week Low price of ₹263.3